» Articles » PMID: 20484923

Comparison of Aerosol and Intranasal Challenge in a Mouse Model of Allergic Airway Inflammation and Hyperresponsiveness

Overview
Date 2010 May 21
PMID 20484923
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim was to optimize antigen challenge for induction of airway hyperresponsiveness (AHR) and inflammation in BALB/c mice sensitized to ovalbumin (OVA). Comparisons were made between mice challenged with OVA either as an aerosol or intranasally. The protocol that induced maximal AHR in BALB/c mice was thereafter tested in C57BL/6 mice.

Method: Methacholine responsiveness was measured using the flexiVent® system to assess AHR. Inflammatory responses were investigated by histology and cell counts in bronchoalveolar lavage (BAL) fluid.

Results: 48 h after challenge with 1 or 6% OVA aerosols, there were similar increments in AHR and BAL cells, predominantly eosinophils. When comparing the effect of 1% OVA aerosol on AHR and cell infiltration at 24 and 48 h after challenge, the responses were similar. At 24 h, intranasal OVA administration (20-200 μg) caused a dose-dependent increase in AHR. BAL cells were increased by all intranasal OVA doses and to a greater extent than after 1% OVA aerosol challenge but without any dose dependency. Histological examination confirmed that there was an increase of eosinophils in lung tissue following either challenge. In C57BL/6 mice, baseline tissue elastance was the only functional outcome that was increased after intranasal OVA challenge. Even though the AHR response was negligible in C57BL/6 mice, a similar infiltration of BAL cells was observed in both strains.

Conclusion: Intranasal challenge was more effective than aerosol challenge at inducing both AHR and airway inflammation in BALB/c mice. Although intranasal challenge caused airway inflammation in C57BL/6 mice, this strain is not optimal for studying AHR.

Citing Articles

Lung stiffness of C57BL/6 versus BALB/c mice.

Rojas-Ruiz A, Boucher M, Gill R, Gelinas L, Tom F, Fereydoonzad L Sci Rep. 2023; 13(1):17481.

PMID: 37838793 PMC: 10576825. DOI: 10.1038/s41598-023-44797-x.


Pharmacological OGG1 inhibition decreases murine allergic airway inflammation.

Tanner L, Bergwik J, Bhongir R, Pan L, Dong C, Wallner O Front Pharmacol. 2022; 13:999180.

PMID: 36324676 PMC: 9619105. DOI: 10.3389/fphar.2022.999180.


Drug class effects on respiratory mechanics in animal models: access and applications.

Oliveira M, Lino-Alvarado A, Moriya H, Vitorasso R Exp Biol Med (Maywood). 2021; 246(9):1094-1103.

PMID: 33601911 PMC: 8113734. DOI: 10.1177/1535370221993095.


Investigation of the relationship between chronic montelukast treatment, asthma and depression-like behavior in mice.

Tel B, Telli G, Onder S, Nemutlu E, Bozkurt T Exp Ther Med. 2020; 21(1):27.

PMID: 33262813 PMC: 7690246. DOI: 10.3892/etm.2020.9459.


Crystalline silica particles cause rapid NLRP3-dependent mitochondrial depolarization and DNA damage in airway epithelial cells.

Wu R, Hogberg J, Adner M, Ramos-Ramirez P, Stenius U, Zheng H Part Fibre Toxicol. 2020; 17(1):39.

PMID: 32778128 PMC: 7418441. DOI: 10.1186/s12989-020-00370-2.